Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Deep Brain Stimulation Helps Those With Advanced Parkinson's


Related Encyclopedia
 border=
Acoustic Neurinoma
Alzheimer's Disease
Arthritis
Arthroscopy & Arthroscopic Surgery
More...

Related Healthscout Videos
 border=
Taking Steps After a Stroke
GPS for the Spine
Custom Ankle Replacements
Custom Ankle Replacements
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Erectile Dysfunction
What is a Heart Attack?
More...

Related Drug Information
 border=
Actonel
Adderal XR
Concerta
Coumadin
More...

Related News Articles
 border=
Might Surgical Weight Loss Put Bones at Risk?
Health Tip: Managing Febrile Seizures
Health Care Reform, Swine Flu Top Health News for 2009
As Problems Accumulate, Frailty May Set In
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

As Parkinson's advances, motor symptoms are often accompanied by anxiety, depression and other non-motor symptoms.

Generally, DBS, a procedure which involves placing a thin wire that can carry electrical currents deep within the brain, is performed after patients are already failing on their medications.

For this study, 255 Parkinson's patients were randomized to receive either DBS or "best medical therapy." One-quarter of the participants were 70 or older, a population underrepresented in previous trials.

Text Continues Below



DBS was targeted either to the subthalamic nucleus (same as current practice) or to the globus pallidus; results of that comparison are forthcoming.

After six months, participants in the DBS arm gained about 4.6 hours per day of "on time," meaning time without troubling movement problems, compared with no gain for patients on best medical therapy.

Seventy-one percent of DBS patients, and only 32 percent of patients in the control group, experienced "clinically meaningful motor function improvements." Those receiving DBS also reported improvements in quality of life.

However, at least one serious adverse event occurred in 49 of the DBS patients vs. 15 in the other group.

Those receiving DBS also experienced small problems with cognitive functioning similar to patterns seen in previous studies and had more falls resulting in fractures and other injuries.

Although both younger and older patients gleaned similar benefits from DBS, older patients were more prone to adverse effects.

This "landmark" study, said Marks, "proved superior for such patients, rather than a tweak-and-adjustment [of medications] approach."

Hopefully, he added, the findings will encourage more neurologists to consider DBS for appropriate patients.

"I think this is going to spur those people who have still been on the fence about DBS to feel comfortable with it," Marshall said.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 1/6/2009

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





SOURCES: William J. Marks Jr., M.D., associate professor, neurology, University of California, San Francisco, and director, San Francisco VA Parkinson's Disease Research, Education & Clinical Center; Fred Marshall, M.D., medical director, deep brain stimulation program, University of Rochester Medical Center, New York; Irene Richard, M.D., associate professor, neurology and psychiatry, University of Rochester Medical Center, New York; Carlos Singer, M.D., director, Parkinson's Disease Center, and professor, neurology, University of Miami Miller School of Medicine; Jan. 7, 2009, Journal of the American Medical Association


About The HealthScout Network Contact Us
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy